Healthy Skepticism Library item: 5947

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Tanne J.
JAMA's editor stresses authors' need to disclose financial ties.
BMJ 2006 Aug 19; 333:(7564):370
http://bmj.bmjjournals.com/cgi/content/short/333/7564/370-c?etoc%3e

Abstract:

JAMA’s editor stresses authors’ need to disclose financial ties
New York Janice Tanne

The editor of JAMA, the Journal of the American Medical Association, has said that the journal would continue its efforts, begun in 1985, to make readers aware of the financial ties of authors.

In an editorial published online ahead of print on 8 August, JAMA’s editor, Catherine DeAngelis, states, “Peer-reviewed medical journals must always place the interests of patients above all else” (www.jama-assn.org, doi:10.1001/jama.296.8.jed60051).

“I think it’s very important now. At least in the United States, the vast majority of clinical research is paid for by drug companies. There’s nothing wrong with that. Somebody’s got to pay for research,” Dr DeAngelis told the BMJ. But when authors fail to disclose ties with drug companies, readers may perceive that authors have something to hide, she added. “In my editorial I went way out of my way to say that even in . . .